Health Care Economics

In Curable journalist and health care advocate Travis Christofferson looks at medicine through a magnifying glass and asks an important question: What if the roots of the current US health care crisis are psychological and systemic, perpetuated not just by corporate influence and the powers that be, but by you and me? Curable outlines the future of medicine, detailing brilliant examples of new health care systems that prove we can do better. It turns out we have more control over our health (and happiness) than we think.

From the origins of consumerism to the evolution or revolution associated with consumerism in healthcare, this audiobook is a reflective depiction of the past, present, and future of healthcare as it empowers the consumer (patient). The Impact of Autonomy and Consumerism in Healthcare navigates the changing healthcare landscape, navigating some of these changes and what they mean not only for healthcare delivery but for providers, suppliers, and consumers.

A bold new remedy for the sprawling and wasteful health care industry. In this provocative book, Jonathan Bush, cofounder and CEO of athenahealth, calls for a revolution in health care to give customers more choices, freedom, power, and information, and at far lower prices.

In the American healthcare system, ignorance is not bliss. We are all paying the price for ever-increasing medical costs and the accompanying loss of quality care.

From a MacArthur Genius ​MIT economist and pre-eminent Stanford economist comes a lively and provocative proposal for American health insurance reform Few of us need convincing that the American health insurance system needs reform. But many of the existing proposals focus on expanding one...

The U.S. healthcare system is in critical condition--but this should come as a surprise to no one. Yet until now the solutions proposed have been unworkable, pie-in-the-sky plans that have had little chance of becoming law and even less of succeeding. In Code Red, David Dranove, one of the nation's leading experts on the economics of healthcare, proposes a set of feasible solutions that address access, efficiency, and quality.

America's leaders say the economy is strong and getting stronger. But the safety net that once protected us is fast unraveling. With retirement plans in growing jeopardy while health coverage erodes, more and more economic risk is shifting from government and business onto the fragile shoulders of the American family. In The Great Risk Shift, Jacob S. Hacker lays bare this unsettling new economic climate, showing how it has come about, what it is doing to our families, and how we can fight back.

A lively, clear explanation of the American healthcare reform movement from a noted expert—giving women the tools they need to demand fair and affordable coverage for all people Healthcare is one of America’s most dysfunctional and confusing industries, and women bear the brunt of the...

From award-winning ProPublica reporter Marshall Allen, a primer for anyone who wants to fight the predatory health care system--and win. Every year, millions of Americans are overcharged and underserved while the health care industry makes record profits. We know something is wrong, but the...

Six Sigma Healthcare delivery means helping improve patient outcomes while driving down the cost of patient care. Doing so empowers healthcare providers to become more productive. Now, more than ever, the healthcare industry needs to embrace the economic value proposition of improving productivity. Healthcare sector can learn a good deal from industries that are working toward the Six Sigma goal. Let's try it in healthcare and see how close we can get.

How a miracle treatment turned deadly and changed the course of the AIDS crisis. By the mid 1980s, AIDS hysteria was so rampant that a fearful and prejudiced public ignored stories of gay men falling ill with lesions and mouth ulcers. President Reagan avoided mentioning the disease entirely...

Here is a bracing deconstruction of the framework for understanding the world that is learned as gospel in Economics 101, regardless of its imaginary assumptions and misleading half-truths. Economism: an ideology that distorts the valid principles and tools of introductory college economics...

Uwe Reinhardt was a towering figure and moral conscience of health care policy in the United States and beyond. Famously bipartisan, he advised presidents and Congress on health reform and originated central features of the Affordable Care Act. In Priced Out, Reinhardt offers an engaging and enlightening account of today's US health care system, explaining why it costs so much more and delivers so much less than the systems of every other advanced country, why this situation is morally indefensible, and how we might improve it.

There was a time in this country when people who were well-off had two homes, and the super-rich may have had three residences. In 2008 a prominent politician was asked how many homes he had. He didn’t know. The number was eight...and in the ensuing years the income gap has only widened. Billionaires now have so much money and power that the very fabric of our nation is coming unraveled. Tax policy is fundamental to a nation’s stability. We need to return to the system that brought us a large, dynamic, educated middle class.

Seine Idee rettet Millionen Menschenleben. Im Jahr 1999 macht Ingmar Hoerr als Doktorand in einem Tübinger Labor eine überraschende Entdeckung: mRNA funktioniert als Impfstoff. Über zwanzig Jahre später schützt sich die Welt mit eben solchen mRNA-Impfstoffen vor dem Coronavirus: mit den Vakzinen von BioNTech, Moderna und CureVac. Zwischen Experiment und Triumph liegen zwei Jahrzehnte hartnäckigen Forschens. Mehrfach wäre Ingmar Hoerr mit CureVac fast gescheitert, hätte er nicht Dietmar Hopp, Bill Gates und Elon Musk von seiner Vision überzeugt.

Antibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Resistance develops because the bacteria that antibiotics target can evolve ways to defend themselves against these drugs. When antibiotics fail, there is very little else to prevent an infection from spreading. Unnecessary use of antibiotics in both humans and animals accelerates the evolution of drug-resistant bacteria, with potentially catastrophic personal and global consequences.

Each year thousands of people die waiting for organ transplants. Many of these deaths could have been prevented were it not for the almost universal moral hand-wringing over the concept of selling human organs. Author and bioethicist Mark Cherry reasserts the case that health care could be improved and lives saved by introducing a regulated transplant organs market rather than by well-meant, but misguided, prohibitions.

For more than 30 years, Hank Cardello was an executive and adviser to some of the largest food and beverage corporations in the world. For more than 30 years, he watched as corporate profits - and America's waistlines - ballooned: fattening consumers meant fattening profits. Now, in this fascinating and timely book, Cardello offers a behind-the-scenes look at the business of food.

When an epidemic outbreak occurs, the most physical and financial harm historically falls upon the people who can least afford it: the economically and socially marginalized. Where people live and work, how they commute and socialize, and more have a huge impact on the risks we bear during an outbreak. In The Rich Flee and the Poor Take the Bus, economist Troy Tassier examines examples ranging from the 430 BCE plague of Athens to the COVID-19 pandemic to demonstrate why marginalized groups bear the largest burden of epidemic costs-and how to avoid these systemic failures in the future.

Alles begann mit einer Doktorarbeit und der Entdeckung des medizinischen Potenzials des Botenmoleküls messenger RNA. Am Ende stehen prominente Investoren wie Dietmar Hopp oder die Gates-Stiftung, Hunderte Millionen staatlicher Finanzierung, der Aufstieg zum Börsenstar und zum erfolgreichen Impfstoffentwickler. Dazwischen liegt ein steiniger Weg auf der Suche nach Unterstützung. Biotech-Unternehmer Wolfgang Klein hat die Anfangszeit als Finanzchef von CureVac selbst miterlebt. Er erzählt die einzigartige und anekdotenreiche Geschichte auf dem Weg zum Weltunternehmen.